KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00 at Lake Street Capital

KORU Medical Systems (NASDAQ:KRMD) had its price target increased by investment analysts at Lake Street Capital from $4.00 to $5.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s target price indicates a potential upside of 26.90% from the stock’s previous close.

Several other research analysts have also issued reports on KRMD. Piper Sandler increased their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Canaccord Genuity Group increased their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Craig Hallum boosted their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $4.30.

KORU Medical Systems Price Performance

Shares of NASDAQ KRMD opened at $3.94 on Tuesday. KORU Medical Systems has a 1 year low of $1.98 and a 1 year high of $4.60. The stock has a market capitalization of $180.60 million, a P/E ratio of -15.76 and a beta of 0.45. The company’s 50-day moving average is $3.75 and its 200 day moving average is $2.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37.

Institutional Investors Weigh In On KORU Medical Systems

Several hedge funds have recently added to or reduced their stakes in the stock. XTX Topco Ltd bought a new position in shares of KORU Medical Systems during the third quarter valued at $34,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in KORU Medical Systems during the 2nd quarter valued at about $107,000. Connor Clark & Lunn Investment Management Ltd. raised its holdings in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after buying an additional 26,860 shares during the last quarter. Empire Financial Management Company LLC purchased a new position in KORU Medical Systems in the third quarter worth about $259,000. Finally, Geode Capital Management LLC lifted its stake in shares of KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after buying an additional 28,323 shares in the last quarter. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.